These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 27201466)

  • 1. Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Health Care Unit (Asln°1) Of Milan: A Results Of Intervention On Secondary Prevention.
    Di Matteo S; Colombo GL; Malnis D; Bruno GM
    Value Health; 2014 Nov; 17(7):A492. PubMed ID: 27201466
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS and microscale NMR analysis of luciferin-related compounds from the bioluminescent earthworm Fridericia heliota.
    Marques SM; Petushkov VN; Rodionova NS; da Silva JC
    J Photochem Photobiol B; 2011 Mar; 102(3):218-23. PubMed ID: 21216615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit.
    Winning J; Neumann J; Kohl M; Claus RA; Reinhart K; Bauer M; Lösche W
    Crit Care Med; 2010 Jan; 38(1):32-7. PubMed ID: 19770746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.
    Piepoli MF; Corrà U; Benzer W; Bjarnason-Wehrens B; Dendale P; Gaita D; McGee H; Mendes M; Niebauer J; Zwisler AD; Schmid JP;
    Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):1-17. PubMed ID: 19952757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease.
    Gogovor A; Dragomir A; Savoie M; Perreault S
    Value Health; 2007; 10(5):431-41. PubMed ID: 17888108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis.
    Vegter S; Oosterhof P; van Boven JF; Stuurman-Bieze AG; Hiddink EG; Postma MJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):722-32. PubMed ID: 24967525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of critical care.
    LaRovere JM; Jeffries HE; Sachdeva RC; Rice TB; Wetzel RC; Cooper DS; Bird GL; Ghanayem NS; Checchia PA; Chang AC; Wessel DL
    Cardiol Young; 2008 Dec; 18 Suppl 2():130-6. PubMed ID: 19063783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative health-care utilization in Crohn's disease: the impact of specialist care.
    Nguyen GC; Saibil F; Steinhart AH; Li Q; Tinmouth JM
    Am J Gastroenterol; 2012 Oct; 107(10):1522-9. PubMed ID: 22850430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary medical prevention and clinical outcome in coronary artery disease patients with a history of non-coronary vascular intervention: A report from the CORONOR investigators.
    Delsart P; Lemesle G; Lamblin N; Tricot O; Meurice T; Mycinski C; Elkohen M; Chmait A; Haulon S; Bauters C
    Eur J Prev Cardiol; 2015 Jul; 22(7):864-71. PubMed ID: 24914029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care.
    Ketola E; Mäkelä M; Klockars M
    Br J Gen Pract; 2001 Apr; 51(465):291-4. PubMed ID: 11458482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services.
    Tu JV; Chu A; Donovan LR; Ko DT; Booth GL; Tu K; Maclagan LC; Guo H; Austin PC; Hogg W; Kapral MK; Wijeysundera HC; Atzema CL; Gershon AS; Alter DA; Lee DS; Jackevicius CA; Bhatia RS; Udell JA; Rezai MR; Stukel TA
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):204-12. PubMed ID: 25648464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients.
    Tarasiuk A; Greenberg-Dotan S; Brin YS; Simon T; Tal A; Reuveni H
    Chest; 2005 Sep; 128(3):1310-4. PubMed ID: 16162723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of an acute venous thromboembolism clinical pathway reduces healthcare utilization and mitigates health disparities.
    Misky GJ; Carlson T; Thompson E; Trujillo T; Nordenholz K
    J Hosp Med; 2014 Jul; 9(7):430-5. PubMed ID: 24639293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking clinical care to community resources for cardiovascular disease prevention: the North Carolina Enhanced WISEWOMAN project.
    Jilcott SB; Keyserling TC; Samuel-Hodge CD; Rosamond W; Garcia B; Will JC; Farris RP; Ammerman AS
    J Womens Health (Larchmt); 2006 Jun; 15(5):569-83. PubMed ID: 16796484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' and providers' perspectives of a polypill strategy to improve cardiovascular prevention in Australian primary health care: a qualitative study set within a pragmatic randomized, controlled trial.
    Liu H; Massi L; Laba TL; Peiris D; Usherwood T; Patel A; Cass A; Eades AM; Redfern J; Hayman N; Howard K; Brien JA; Jan S
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):301-8. PubMed ID: 25944629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.